Last reviewed · How we verify
Long-Term Varenicline — Competitive Intelligence Brief
preclinical
Varenicline tablet x 24 weeks
Other
Live · refreshed every 30 min
Target snapshot
Long-Term Varenicline (long-term-varenicline) — Pfizer Inc.. Varenicline tablet x 24 weeks
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Long-Term Varenicline TARGET | long-term-varenicline | Pfizer Inc. | preclinical | Varenicline tablet x 24 weeks |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Varenicline tablet x 24 weeks class)
- Pfizer Inc. · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Long-Term Varenicline CI watch — RSS
- Long-Term Varenicline CI watch — Atom
- Long-Term Varenicline CI watch — JSON
- Long-Term Varenicline alone — RSS
- Whole Varenicline tablet x 24 weeks class — RSS
Cite this brief
Drug Landscape (2026). Long-Term Varenicline — Competitive Intelligence Brief. https://druglandscape.com/ci/long-term-varenicline. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing